AU7865791A - Anti-actinic agent - Google Patents
Anti-actinic agentInfo
- Publication number
- AU7865791A AU7865791A AU78657/91A AU7865791A AU7865791A AU 7865791 A AU7865791 A AU 7865791A AU 78657/91 A AU78657/91 A AU 78657/91A AU 7865791 A AU7865791 A AU 7865791A AU 7865791 A AU7865791 A AU 7865791A
- Authority
- AU
- Australia
- Prior art keywords
- actinic
- agent
- actinic agent
- nicotinamide
- systemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Liquid Crystal (AREA)
- Prostheses (AREA)
- Glass Compositions (AREA)
Abstract
The invention relates to the use of nicotinamide, folic acid and/or combinations thereof for systemic and/or topical prophylaxis of the damaging effect of light on skin and to a suitable anti-actinic agent.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4018964A DE4018964C1 (en) | 1990-06-13 | 1990-06-13 | |
DE4018964 | 1990-06-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7865791A true AU7865791A (en) | 1992-01-07 |
AU645092B2 AU645092B2 (en) | 1994-01-06 |
Family
ID=6408360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU78657/91A Ceased AU645092B2 (en) | 1990-06-13 | 1991-05-24 | Anti-actinic agent |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0486632B1 (en) |
JP (1) | JPH0635387B2 (en) |
AT (1) | ATE108993T1 (en) |
AU (1) | AU645092B2 (en) |
CA (1) | CA2059641A1 (en) |
DE (2) | DE4018964C1 (en) |
ES (1) | ES2061248T3 (en) |
WO (1) | WO1991019478A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4341001A1 (en) * | 1993-12-02 | 1995-06-08 | Beiersdorf Ag | Topical preparations containing L-arginine |
US5759524A (en) * | 1996-02-09 | 1998-06-02 | The Procter & Gamble Company | Photoprotective compositions |
DE10021468A1 (en) * | 2000-05-04 | 2001-11-08 | Basf Ag | Use of PARP inhibitors in cosmetic preparations |
DE10062401A1 (en) * | 2000-12-14 | 2002-06-20 | Beiersdorf Ag | Use of folic acid and / or derivatives thereof for the preparation of cosmetic or dermatological preparations for the prophylaxis of damage to the skin's own DNA and / or to repair damage already occurred to the skin's own DNA |
CH696628A5 (en) * | 2002-02-26 | 2007-08-31 | Eprova Ag | Use of folate suitable for the manufacture of a preparation for the prevention and treatment of inflammation and inflammation-associated diseases, in particular for influencing the |
US20040191278A1 (en) | 2003-03-31 | 2004-09-30 | Christensen Flemming Kjaergaar | Topical agent for application to the skin prior to luminous treatment |
ES2292280B2 (en) * | 2004-12-01 | 2008-12-01 | Antonio Navarro Perez | SUPPORT ANCHOR SYSTEM FOR WORK PROTECTION NETWORKS. |
FR2894142B1 (en) * | 2005-12-05 | 2009-06-12 | Oreal | USE OF THE TYROSINE-ARGININE DIPEPTIDE AND NIACIMANIDE ASSOCIATION AS A P-SUBSTANCE ANAGONIST |
US8858968B2 (en) | 2005-12-05 | 2014-10-14 | L'oreal | Use of tyrosine-arginine dipeptide and niacinamide as substance P antagonist |
KR101275351B1 (en) * | 2010-06-29 | 2013-06-17 | (주)아모레퍼시픽 | Cosmetic Composition for Preventing Skin Aging |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2096712A1 (en) * | 1970-06-29 | 1972-02-25 | Giraux Georges | Steroid/b group vitamin compsns - for prevention and treatment of skin-photosensitivity disorders |
DE2242553A1 (en) * | 1972-08-30 | 1974-03-07 | Koehler Valentin | Cosmetic compsns contg folic acid or its salts - exerting antiseborrhoic effect and suppressing skin ageing |
JPS59173124A (en) * | 1983-03-19 | 1984-10-01 | Shiseido Co Ltd | Emulsified composition |
LU87145A1 (en) * | 1988-02-26 | 1989-09-20 | Oreal | METHOD FOR IMPROVING THE AESTHETIC APPEARANCE OF THE SKIN USING POLYVITAMIN MIXTURES |
-
1990
- 1990-06-13 DE DE4018964A patent/DE4018964C1/de not_active Expired - Lifetime
-
1991
- 1991-05-24 CA CA002059641A patent/CA2059641A1/en not_active Abandoned
- 1991-05-24 DE DE59102350T patent/DE59102350D1/en not_active Expired - Fee Related
- 1991-05-24 AT AT91909455T patent/ATE108993T1/en active
- 1991-05-24 JP JP3509066A patent/JPH0635387B2/en not_active Expired - Lifetime
- 1991-05-24 WO PCT/DE1991/000433 patent/WO1991019478A1/en active IP Right Grant
- 1991-05-24 EP EP91909455A patent/EP0486632B1/en not_active Expired - Lifetime
- 1991-05-24 AU AU78657/91A patent/AU645092B2/en not_active Ceased
- 1991-05-24 ES ES91909455T patent/ES2061248T3/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2059641A1 (en) | 1991-12-14 |
WO1991019478A1 (en) | 1991-12-26 |
AU645092B2 (en) | 1994-01-06 |
EP0486632B1 (en) | 1994-07-27 |
JPH05500230A (en) | 1993-01-21 |
EP0486632A1 (en) | 1992-05-27 |
JPH0635387B2 (en) | 1994-05-11 |
ATE108993T1 (en) | 1994-08-15 |
ES2061248T3 (en) | 1994-12-01 |
DE4018964C1 (en) | 1991-07-04 |
DE59102350D1 (en) | 1994-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6985691A (en) | Pharmaceutical and cosmetic compositions | |
AU697584B2 (en) | Retinoid formulations in porous microspheres for reduced irritation and enhanced stability | |
AU5296593A (en) | Concentrated mouthrinse for efficient delivery of antimicrobials | |
AU532114B2 (en) | Salts of n-substituted-2-pyrrolidone-4-carboxylic acids | |
GR3003569T3 (en) | ||
AU8626191A (en) | Pyrimidine derivative, production thereof, and androgen inhibitor | |
AU645092B2 (en) | Anti-actinic agent | |
AU7270794A (en) | Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors | |
DE69431162D1 (en) | Fenbendazolformulierungen | |
AU4445089A (en) | Lactamimides in the treatment of drug-resistant protozoal infections | |
AU635870B2 (en) | Hydrazone derivatives, processes for production thereof, and uses thereof | |
AU2302288A (en) | 4-quinoline-3-carboxylic acid derivatives and their use as antibacterial agents | |
AU2861389A (en) | Disubstituted pyridines | |
FI911207A0 (en) | Process for the preparation of new therapeutically useful retinoid | |
PT910367E (en) | USE OF VITAMIN E ACETATE | |
AU641279B2 (en) | Oligosaccharide derivatives | |
ES2174113T3 (en) | NEW DERIVATIVES OF ((3-ALCOXI-FENOXI) -ETIL) -DIALQUILAMINE AND ITS USE AS LOCAL ANESTHETICS. | |
AU508605B2 (en) | 4, 5-Diaryl-2-Mercaptoimidazole derivatives and their use asanti-inflammatory and immunosuppressive agents | |
AU8844091A (en) | Novel dihydroquinoline derivatives, pharmaceutical compositions and methods of use of dihidroquinoline derivatives as modulators of the arachidonic acid cascade | |
AU3959889A (en) | Benzimidazole derivatives, and their production and use | |
AU3070192A (en) | Uses of 1,1,1,3,3,3-hexafluoropropane | |
AU5589294A (en) | Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors | |
DE3869156D1 (en) | FUNGICIDE 2-ANILINTHIAZOLINE. | |
AU533275B2 (en) | 2-amino or 2-thio derivatives of 4,5-diphenyl-oxazole | |
TR27776A (en) | 2-oxymino-2-thienyl-acetic acid derivatives. |